Grufity logo
Grufity logo
LIVN

LIVN - LivaNova PLC Stock Price, Fair Value and News

$78.18-0.75 (-0.95%)
Market Closed as of 10 Sep 2026, 04:00 pm ET

50/100

LIVN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

50/100

LIVN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

LIVN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LIVN Price Action

Last 7 days

-3.7%

Last 30 days

-0.5%

Last 90 days

-1.5%

Trailing 12 Months

38.3%

LIVN RSI Chart

LIVN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

LIVN Valuation

Market Cap

4.3B

Price/Earnings (Trailing)

22.84

Price/Sales (Trailing)

2.93

EV/EBITDA

23.3

Price/Free Cashflow

29.04

LIVN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

Login to View

Target 6M

Login to View

LIVN Fundamentals

LIVN Revenue

Revenue (TTM)

1.5B

Rev. Growth (Yr)

10.8%

Rev. Growth (Qtr)

7.82%

LIVN Earnings

Earnings (TTM)

188.6M

Earnings Growth (Yr)

299.72%

Earnings Growth (Qtr)

386.99%

LIVN Profitability

EBT Margin

7.31%

Return on Equity

14.23%

Return on Assets

7.14%

Free Cashflow Yield

3.44%

LIVN Investor Care

Shares Dilution (1Y)

0.92%

Diluted EPS (TTM)

3.39

LIVN Alerts

  • 3 major insider sales recently.
  • Big jump in Earnings (Y/Y)
Revenue & Growth

How LivaNova PLC generates revenue and covers its expenses, based on the latest reported earnings.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)
Net sales
YearQ1Q2Q3Q4
20261.4B1.5B--
20251.3B1.3B1.3B1.4B
20241.2B1.2B1.2B1.3B
20231.0B1.1B1.1B1.2B
20221.0B1.0B1.0B1.0B
2021939.4M1.0B1.0B1.0B
20201.1B980.8M952.3M934.2M
20191.1B1.1B1.1B1.1B
20181.0B1.1B1.1B1.1B
2017782.5M799.8M983.6M1.0B
2016640.9M811.4M982.4M782.7M
2015253.7M255.8M263.4M294.7M
2014275.1M282.0M285.1M288.5M
2013-254.3M261.2M268.2M
Get all data in R, Python etc through our Historical Stock Data APIs(opens in new tab)

About LivaNova PLC

LIVN
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device that delivers vagus nerve stimulation (VNS) therapy for the treatment of drug-resistant epilepsy, difficult-to-treat depression, and obstructive sleep apnea. It is also involved in the development and clinical testing of the VITARIA System for treating heart failure through VNS. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. It also engages in research collaboration with Verily to capture clinical biomarkers of depression. LivaNova PLC was founded in 1987 and is headquartered in London, the United Kingdom.
 CEO
 WEBSITElivanova.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES2900

LivaNova PLC Frequently Asked Questions

LIVN is the stock ticker symbol of LivaNova PLC. Every public company that trades on a stock exchange gets a ticker symbol.

As of Thu Sep 10 2026, market cap of LivaNova PLC is 4.31 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

As of Thu Sep 10 2026, LIVN's PE ratio (Price to Earnings) is 22.84 and Price to Sales (PS) ratio is 2.93. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. LIVN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, LivaNova PLC has provided 0.027 (multiply by 100 for percentage) rate of return.